NYSE American · Medical Devices · USD
Phaos Technology Holdings (Caym (POAS) Stock Analysis
Phaos Technology Holdings (Caym (POAS) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
POAS Key Statistics
As of Oct 21, 2026Trading
- Open
- $2.01
- Previous Close
- $2.42
- Day's Range
- 2.01–2.57
- 52-Week Range
- 1.84–110.93
- Volume
- 40.53K
Valuation
- Market Cap
- $2.51M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 18.97
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −5.72
Financials (FY)
- Revenue (FY)
- $167.71K−91.09%
- Net Income (FY)
- −$5.14M
- Shares Outstanding
- 1.10M
Dividend and dates
- Avg Volume
- 35.99K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
Phaos Technology Holdings (Caym (POAS) has a market capitalization of $2.51M.
In fiscal 2024, POAS reported revenue of $167.71K.
POAS Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −33.38% |
| 2025 (partial year) | −10.91% |
As of October 21, 2026.
POAS Revenue and Earnings by Fiscal Year
FY ends April| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2024 | $167.71K | −$5.14M | −3,063.1% |
| 2023 | $1.88M | −$2.36M | −125.3% |
| 2022 | $650.80K | −$1.67M | −256.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2024 | $167.71K | $37.07K | −$3.99M | −$5.14M | −3,063.1% |
| 2023 | $1.88M | $811.17K | −$2.39M | −$2.36M | −125.3% |
| 2022 | $650.80K | $114.63K | −$1.68M | −$1.67M | −256.3% |
Annual figures as reported, in the company's reporting currency. As of April 30, 2025.
POAS Valuation vs Medical Devices Median
Median of 145 stocks| Metric | POAS | Medical Devices median | vs median |
|---|---|---|---|
| P/S ratio | 18.97 | 2.53 | 7.5x the median |
Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Phaos Technology Holdings (Cayman) Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2026
YahooPhaos Technology Holdings (Cayman) Limited Announces One-For-Fifteen Reverse Stock Split
YahooPhaos Technology Holdings (Cayman) Limited Announces Entry Into Securities Purchase Agreement for an Equity Facility of Up to US$10 Million
YahooPhaos Technology Inks $10M Securities Purchase Agreement With High West Partners
BenzingaPhaos Technology Holdings (Cayman) Limited Announces Update on Involvement of Related Parties
YahooPhaos Technology Holdings (Cayman) Limited Announces Results of Extraordinary General Meeting
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$173.92B
MDTMedtronic plc.
$119.00B
SYKStryker Corporation
$114.15B
BSXBoston Scientific Corporation
$64.33B
EWEdwards Lifesciences Corporation
$50.95B
GEHCGE HealthCare Technologies Inc.
$31.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B